CM-118
CM-118 is a potent and selective c-Met and ALK inhibitor. CM-118 inhibits the HGF-induced c-Met phosphorylation. CM-118 inhibits phosphorylation of ALK, EML4-ALKv1, ALK F1174L, and EMl4-ALKv1 L1196M, with respective IC50 values 0.92, 1.25, 1.9, and 3.5 μM. CM-118 exhibits anticancer activity against cancers dependent on the c-Met or ALK oncogenic pathways[1].
Product Specifications
CAS Number
1370652-56-4
UNSPSC
12352005
Target
Anaplastic lymphoma kinase (ALK) ; c-Met/HGFR
Related Pathways
Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Smiles
C[C@H](C1=C(C(F)=CC=C1Cl)Cl)OC2=C(N)N=NC(C(NC3=CN(C(C=C3)=O)C)=O)=C2
Molecular Formula
C19H16Cl2FN5O3
Molecular Weight
452.27
References & Citations
[1]Meng L, et al. A novel lead compound CM-118: antitumor activity and new insight into the molecular mechanism and combination therapy strategy in c-Met- and ALK-dependent cancers. Cancer Biol Ther. 2014 Jun 1;15 (6) :721-34.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
VAng-Lsx3488-500gEcoli 500 µg (E. coli)
Recombinant Helicobacter Pylori ndk Protein (aa 1-137)
Sign In for Pricing
View Details 
224167-01 50 µL
MGluR-2/3 (Metabotropic Glutamate Receptor 2, mGluR2, GRM2, GPRC1B, MGLUR2, Metabotropic Glutamate Receptor 3, mGluR3, GRM3, GPRC1C, MGLUR3) discontinued
Sign In for Pricing
View Details 224167-02 100 µL
MGluR-2/3 (Metabotropic Glutamate Receptor 2, mGluR2, GRM2, GPRC1B, MGLUR2, Metabotropic Glutamate Receptor 3, mGluR3, GRM3, GPRC1C, MGLUR3) discontinued
Sign In for Pricing
View Details 